Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Tang Capital Partners Lp’

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13D Filing: Tang Capital Partners LP and La Jolla Pharmaceutical Co (LJPC)

La Jolla Pharmaceutical Co (NASDAQ:LJPC): Kevin C. Tang’s Tang Capital Partners LP filed an amended 13D. You can check out Tang Capital Partners......(read more)

13D Filing: Tang Capital Partners LP and La Jolla Pharmaceutical Co (LJPC)

La Jolla Pharmaceutical Co (NASDAQ:LJPC): Kevin C. Tang’s Tang Capital Partners LP filed an amended 13D. You can check out Tang Capital Partners......(read more)
biotech research company, bio-technology companies

13D Filing: Tang Capital Partners LP and Odonate Therapeutics Inc (ODT)

Odonate Therapeutics Inc (NASDAQ:ODT): Kevin C. Tang’s Tang Capital Partners LP filed an amended 13D. You can check out Tang Capital Management&#......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13D Filing: Tang Capital Partners LP and Cyclacel Pharmaceuticals Inc. (CYCC)

Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC): Kevin C. Tang’s Tang Capital Partners LP filed an amended 13D. You can check out Tang Capital Management......(read more)
trade, forex, investment, gain, stock, phone, network, view, report, money, smart, background, broker, market, laptop, table, economy, display, loss, business, urban,

Heron Therapeutics, Inc. (HRTX): Tang Capital Partners Raises Stake to 17%

According to a newly-amended 13D filing with the US SEC, Kevin C. Tang‘s Tang Capital Management owns 6.53 million shares of Heron Therapeutics......(read more)